WELL Health Improves Guidance Based on WELL Canada Achieving $100 Million in Annualized Adjusted EBITDA Run-Rate Ahead of Schedule
WELL Health Technologies announced it has achieved a $100 million annualized Adjusted EBITDA run-rate for its Canadian segment three quarters ahead of schedule, doing so on $700 million in revenue rather than the previously guided $800 million. This performance implies an Adjusted EBITDA margin of approximately 14%, which is roughly 180 basis points better than prior guidance, prompting the company to raise its 2026 full-year Adjusted EBITDA outlook to exceed the previous top-end of $185 million.
Key figures
- Well canada revenue
- $700 million
- Acquired ebitda 2025
- $22 million
- Acquisition cash paid
- $115 million
- Acquired ebitda margin
- well over 25%
- Canadian clinics count
- 270
- Prior guidance revenue
- $800 million
- Billable providers count
- 2350
- Well canada ebitda margin
- 14%
- Well canada ebitda run rate
- $100 million
- Fy2026 ebitda guidance top end
- $185 million
- Prior guidance ebitda run rate
- $100 million
- Acquisition total potential value
- $160 million
- Fy2026 ebitda guidance bottom end
- $175 million
- Prior guidance ebitda margin implied
- 12.5%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.